Sujal M. Patel - 08 Mar 2024 Form 4 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Signature
/s/ Mathew B. Murphy, as Attorney-in-Fact
Issuer symbol
NAUT
Transactions as of
08 Mar 2024
Transactions value $
$41,478
Form type
4
Filing time
11 Mar 2024, 20:21:59
Previous filing
07 Mar 2024
Next filing
04 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAUT Common Stock Purchase $7.26K +2.43K +0.02% $2.99 10.1M 08 Mar 2024 Direct F1
transaction NAUT Common Stock Purchase $34.2K +12K +0.12% $2.84 10.1M 11 Mar 2024 Direct F2
holding NAUT Common Stock 1.81M 08 Mar 2024 By Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 F3
holding NAUT Common Stock 5.28M 08 Mar 2024 By PFV I, LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 2,430 shares purchased in the price range of $2.96 to $3.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 Represents the weighted average share price of an aggregate total of 12,044 shares purchased in the price range of $2.75 to $3.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
F3 Shares held by Sujal Patel 2020 Children's Trust, u/a/d December 3, 2020 (the "Patel Trust"). The reporting person and the reporting person's spouse are the trustees of the Patel Trust.
F4 Shares held by PFV I, LLC. The reporting person is the manager of PFV I, LLC.